These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17045169)

  • 21. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
    Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
    Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats.
    Nadai M; Kato M; Yasui K; Kimura M; Zhao YL; Ueyama J; Tsunekawa Y; Yoshizumi H; Hasegawa T
    Biol Pharm Bull; 2007 Mar; 30(3):562-8. PubMed ID: 17329857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.
    Meyer PT; Elmenhorst D; Boy C; Winz O; Matusch A; Zilles K; Bauer A
    Neurobiol Aging; 2007 Dec; 28(12):1914-24. PubMed ID: 16996650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
    Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro.
    Granfors MT; Backman JT; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Mar; 57(3):349-53. PubMed ID: 14998432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodibenzofuran in the rat and human.
    Tai HL; McReynolds JH; Goldstein JA; Eugster HP; Sengstag C; Alworth WL; Olson JR
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):34-42. PubMed ID: 8236259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX.
    Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K
    Ann Nucl Med; 2003 Sep; 17(6):511-5. PubMed ID: 14575390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine.
    Kimura Y; Ishii K; Fukumitsu N; Oda K; Sasaki T; Kawamura K; Ishiwata K
    Nucl Med Biol; 2004 Nov; 31(8):975-81. PubMed ID: 15607479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes.
    Piver B; Fer M; Vitrac X; Merillon JM; Dreano Y; Berthou F; Lucas D
    Biochem Pharmacol; 2004 Aug; 68(4):773-82. PubMed ID: 15276085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
    Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of incubation conditions on microsomal metabolism of xanthine-derived A
    Schneider D; Bier D; Bauer A; Neumaier B; Holschbach M
    J Pharmacol Toxicol Methods; 2019; 95():16-26. PubMed ID: 30476620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity.
    Atherton KM; Mutch E; Ford D
    Biochem Pharmacol; 2006 Aug; 72(5):624-31. PubMed ID: 16814747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography.
    Bauer A; Holschbach MH; Meyer PT; Boy C; Herzog H; Olsson RA; Coenen HH; Zilles K
    Neuroimage; 2003 Aug; 19(4):1760-9. PubMed ID: 12948730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2006 Dec; 34(12):2091-6. PubMed ID: 16985100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine.
    Agúndez JA; Gallardo L; Martínez C; Gervasini G; Benítez J
    Pharmacogenetics; 1998 Jun; 8(3):251-8. PubMed ID: 9682270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.
    Lee DY; Jung YS; Kim YC; Kim SY; Lee MG
    Biopharm Drug Dispos; 2009 Apr; 30(3):107-16. PubMed ID: 19288444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.